Is Vilin Bio Med Ltd debt-free?

Yes, Vilin Bio Med Ltd is debt-free with a debt-to-equity ratio of 0.11.

Home

Vilin Bio Med Ltd

Vilin Bio Med Ltd Financials

Vilin Bio Med Ltd Financial Statement

Vilin Bio Med Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2023	Dec 2022
Revenue	3.30	4.94
Operating Expense	3.06	3.69
Net Profit	-0.04	0.73
Net Profit Margin	-1.21	14.78
Earning Per Share	TBA	2.21
EBIDTA	0.24	1.22
Effective Tax Rate	29.17	22.40

Particulars	Mar 2023
Revenue	3.30
Operating Expense	3.06
Net Profit	-0.04
Net Profit Margin	-1.21
Earning Per Share	TBA
EBIDTA	0.24
Effective Tax Rate	29.17

Vilin Bio Med Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	14.81	15.80	12.31
Operating Expenses Annual	14.02	14.99	9.74
Operating Profit Annual	1.26	1.14	2.60
Interest Annual	0.85	0.79	0.65
Depreciation	0.10	0.13	0.17
Net Profit Annual	0.22	0.16	1.25
Tax Annual	0.08	0.06	0.54

Particulars	Mar 2025
Total Revenue Annual	14.81
Operating Expenses Annual	14.02
Operating Profit Annual	1.26
Interest Annual	0.85
Depreciation	0.10
Net Profit Annual	0.22
Tax Annual	0.08

Vilin Bio Med Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	6.05	0.03	0.04
Cash Flow from Operations	0.22	-7.42	-1.66
Cash Flow from Investing	-1.11	0.32	-0.03
Cash Flow from Financing	-5.10	8.87	1.68
Cash Flow at the End	0.06	1.81	0.03

Particulars	Mar 2025
Cash Flow at the Beginning	6.05
Cash Flow from Operations	0.22
Cash Flow from Investing	-1.11
Cash Flow from Financing	-5.10
Cash Flow at the End	0.06

Vilin Bio Med Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	8.51	7.28	21.12
PBIT Margin (%)	7.83	6.46	19.74
PBT Margin (%)	-1.29	-1.64	-10.72
Net PROFIT Margin (%)	1.49	1.01	10.15
Return On Networth / Equity (%)	0.96	0.95	13.83
Return On Networth /Employed (%)	4.16	4.46	17.24
Return On Assets (%)	0.80	0.71	8.83
Total Debt / Equity (X)	0.20	0.35	0.57
Asset Turnover Ratio (%)	0.54	0.70	0.87

Particulars	Mar 2025
PBDIT Margin (%)	8.51
PBIT Margin (%)	7.83
PBT Margin (%)	-1.29
Net PROFIT Margin (%)	1.49
Return On Networth / Equity (%)	0.96
Return On Networth /Employed (%)	4.16
Return On Assets (%)	0.80
Total Debt / Equity (X)	0.20
Asset Turnover Ratio (%)	0.54

Vilin Bio Med Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	1.28	1.38	1.51
Total Current Assets Annual	12.56	18.62	8.05
Non Current Assets Annual	15.17	13.79	9.62
Total Shareholders Funds Annual	23.06	22.84	10.68
Total Assets Annual	27.73	32.40	17.68

Particulars	Mar 2025
Fixed Assets Annual	1.28
Total Current Assets Annual	12.56
Non Current Assets Annual	15.17
Total Shareholders Funds Annual	23.06
Total Assets Annual	27.73

Vilin Bio Med Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Vilin Bio Med Ltd Financials

As of Aug 22, 2025, Vilin Bio Med Ltd has a market capitalization of 28.46 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Vilin Bio Med Ltd is with a debt-to-equity ratio of 0.11.

In FY 2024 , Vilin Bio Med Ltd recorded a total revenue of approximately 14.81 Cr marking a significant milestone in the company's financial performance.

Vilin Bio Med Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.1% annually, respectively..

Vilin Bio Med Ltd's current PE ratio is 129.36.

Vilin Bio Med Ltd's ROCE averaged 7.8% from the FY ending March 2023 to 2025, with a median of 4.5%. It peaked at 15.6% in March 2023, reflecting strong capital efficiency over the period..

Vilin Bio Med Ltd's latest EBIT is Rs. 1.16 Cr, surpassing the average EBIT of Rs. 1.54 Cr over the 5 years..